Press Releases

Date Title and Summary Additional Formats
Toggle Summary NOVELOS THERAPEUTICS TRADING SYMBOL REVERTS TO NVLT
NOVELOS THERAPEUTICS TRADING SYMBOL REVERTS TO NVLT MADISON, WI, May 9, 2011 – Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, announced that today its trading symbol has reverted to NVLT.
View HTML
Toggle Summary NOVELOS THERAPEUTICS WELCOMES FIVE NEW DIRECTORS
NOVELOS THERAPEUTICS WELCOMES FIVE NEW DIRECTORS MADISON, WI, April 26, 2011 – Novelos Therapeutics, Inc. (OTCBB: NVLTD), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that Dr. Rock Mackie, Mr. John Neis, Dr. John Niederhuber, Dr.
View HTML
Toggle Summary NOVELOS THERAPEUTICS COMPLETES ACQUISITION AND $5.1 MILLION FINANCING TO DEVELOP 3 NOVEL CANCER-TARGETED COMPOUNDS
Trading Under Symbol NVLTD for 20 Trading Days to Reflect Reverse Split
View HTML